MedPath

Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study

Not Applicable
Conditions
Malignancy
Registration Number
JPRN-UMIN000018589
Lead Sponsor
The University of Tokyo, The Institute of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with substance withdrawal delirium Patient with postoperative delirium Patients who undergo medical treatments intended to terminal sedation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath